- Home
- FULC vs LEGT Comparison
FULC vs LEGT Comparison
Compare FULC & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- LEGT
- Stock Information
- Founded
- FULC 2015
- LEGT 2023
- Country
- FULC United States
- LEGT United States
- Employees
- FULC N/A
- LEGT N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- LEGT
- Sector
- FULC Health Care
- LEGT
- Exchange
- FULC Nasdaq
- LEGT Nasdaq
- Market Cap
- FULC 221.5M
- LEGT 265.5M
- IPO Year
- FULC 2019
- LEGT 2024
- Fundamental
- Price
- FULC $3.96
- LEGT $10.33
- Analyst Decision
- FULC Hold
- LEGT
- Analyst Count
- FULC 10
- LEGT 0
- Target Price
- FULC $7.44
- LEGT N/A
- AVG Volume (30 Days)
- FULC 1.0M
- LEGT 43.0K
- Earning Date
- FULC 02-25-2025
- LEGT 01-01-0001
- Dividend Yield
- FULC N/A
- LEGT N/A
- EPS Growth
- FULC N/A
- LEGT N/A
- EPS
- FULC N/A
- LEGT N/A
- Revenue
- FULC $80,871,000.00
- LEGT N/A
- Revenue This Year
- FULC $2,821.96
- LEGT N/A
- Revenue Next Year
- FULC N/A
- LEGT N/A
- P/E Ratio
- FULC N/A
- LEGT N/A
- Revenue Growth
- FULC 2987.86
- LEGT N/A
- 52 Week Low
- FULC $2.86
- LEGT $10.00
- 52 Week High
- FULC $13.70
- LEGT $10.47
- Technical
- Relative Strength Index (RSI)
- FULC 41.64
- LEGT N/A
- Support Level
- FULC $3.93
- LEGT N/A
- Resistance Level
- FULC $5.17
- LEGT N/A
- Average True Range (ATR)
- FULC 0.30
- LEGT 0.00
- MACD
- FULC -0.13
- LEGT 0.00
- Stochastic Oscillator
- FULC 3.97
- LEGT 0.00
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.